Treated T Cells Followed by a Stem Cell Transplant in Treating Patients With Multiple Myeloma

Completed · Phase 1

Conditions studied: Multiple Myeloma and Plasma Cell Neoplasm

In brief

RATIONALE: Giving chemotherapy followed by treated T cells before a stem cell transplant stops the growth of cancer cells by stopping them from dividing or by killing them. After treatment, stem cells are collected from the patient's blood and stored. High-dose chemotherapy is given to prepare the bone marrow for the stem cell transplant. The stem cells are then returned to the patient to replace the blood-forming cells that were destroyed by the chemotherapy. PURPOSE: This phase I trial is studying the side effects and best way to give treated T cells followed by stem cell transplant in treating patients with multiple myeloma.

Key facts

Study ID
NCT00938626
Run by
Barbara Ann Karmanos Cancer Institute
People needed
12
Starts
2009-10-01
Expected to finish
2013-03-01
Last updated by the study team
2013-09-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.